Full-Time

Clinical Research Coordinator

Nudge

Nudge

11-50 employees

Non-invasive neuromodulation headset via ultrasound

No salary listed

San Francisco, CA, USA

In Person

On-site in San Francisco, California.

Category
Biology & Biotech (1)

Get referred to Nudge

Find people who can refer or advise you

Requirements
  • Bachelor’s degree in a STEM field or similar
  • Experience in a patient-facing role in clinical trials
  • Experience writing clear and high quality documentation
  • Knowledge of basic medical terminology
  • Strong organizational and communication skills
  • Demonstrated history of exceptional contribution
  • High integrity and strong professional judgement
Responsibilities
  • Manage the participant recruitment process end-to-end, from first contact through prescreening, screening, and consent
  • Maintain and report up-to-date recruitment metrics
  • Serve as the main point of contact for participants in clinical trials
  • Assist with adverse event documentation and reporting
  • Assist in writing and updating clinical study documents (CRFs, SOPs, study protocols, ICFs)
  • Support IRB and other regulatory submissions
  • Develop trial recruitment and other participant-facing materials in accordance with Good Clinical Practice (GCP) guidelines
Desired Qualifications
  • Preference for at least 2 years of professional experience

Generate a concise company summary answering: 1) what the company does, 2) how its product works, 3) how it differs from competitors, 4) its goal, based on the provided description.

Company Size

11-50

Company Stage

Series A

Total Funding

$100M

Headquarters

San Francisco, California

Founded

2025

Get referred to Nudge

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • US $100M Series A led by Thrive and Greenoaks enables top talent recruitment and clinical trials.
  • Nudge Zero, a human-ready system, passed testing three months ago toward clinical validation.
  • EU and US regulatory shifts validate at-home neuromodulation, boosting consumer and healthcare market access.

What critics are saying

  • EU Class III reclassification for non-medical brain stimulation blocks consumer cognitive enhancement pathways.
  • Unproven regulatory path for focused ultrasound may delay FDA clearance for essential tremor and other conditions.
  • Brand confusion with Nudge Security's corporate control products erodes B2C trust and appeals.

What makes Nudge unique

  • Nudge uses focused ultrasound for non-invasive, MRI-verified deep brain circuit modulation.
  • Its dual-purpose device stimulates and images the brain simultaneously with precise targeting.
  • Nudge targets anxiety, OCD, depression, addiction, and chronic pain via neuromodulation.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

31%
EquityBulls
Aug 12th, 2025
FSN E-Commerce acquires 40% Nudge stake

FSN E-Commerce Ventures Ltd has approved the acquisition of the remaining 40% stake in Nudge Wellness Pvt Ltd from Onesto Labs Pvt Ltd, as per the terms of a shareholders' agreement from April 2022. Onesto will no longer hold any stake in Nudge post-transaction. FSN's stock traded at ₹203.60 on BSE, with a high of ₹204.25 and a low of ₹200.25, and a net turnover of ₹9.53 million.

Nudge
Jul 25th, 2025
Announcing Nudge's $100M Series A Fundraise

Nudge - Whole-brain interfaces for everyday life